Revealing the HIV-1 Interactome
Revealing the HIV-1 Interactome
批准号:
8211020
负责人:
MARK AYER MUESING
金额:
$44.72万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-02-15 至 2014-01-31
关键词:
AffinityAntigensAntiviral AgentsBindingBiochemicalBiologicalBiological PreservationBiological ProcessCell physiologyCellsCodeComplexDNADNA VirusesEngineeringEnvironmentEnzymesEpitopesFundingGene TargetingGeneticGenetic CodeGenomeGrowthHIVHIV InfectionsHIV-1HealthHumanHuman ActivitiesInfectionIntegraseIntegration Host FactorsInterventionInvestigationLife Cycle StagesMapsMass Spectrum AnalysisMediatingMethodologyMethodsMutagenesisNuclear ImportProceduresProcessProteinsProteomeProteomicsProtocols documentationReverse TranscriptionSiteSite-Directed MutagenesisSourceStructure-Activity RelationshipSurfaceSurveysSystemT-LymphocyteTechniquesUbiquitinationVaccinesViralViral Envelope ProteinsViral GenomeViral ProteinsVirionVirusbasecryogenicsenv Gene Productsimmunological interventioninsightnovelprotein complexprotein protein interactionrecombinant virussmall moleculesoundtoolvif Gene Productsviral DNA
中文摘要
描述(由申请人提供):鉴于HIV-1的遗传编码能力有限,可以合理预期病毒必须与大量细胞因子相互作用才能完成其通过细胞的过程。事实上,值得注意的是,病毒基因组只占细胞全部遗传能力的0.0003%,却能利用细胞环境为自己谋利。然而,迄今为止,尽管是最容易被研究的病毒,但只有相对较少的一组细胞蛋白质被证明是HIV-1繁殖所必需的。已经开发了一种遗传/蛋白质组学方法,该方法利用随机诱变方案,然后进行严格的生物选择步骤,以努力查明HIV-1蛋白质组内的那些罕见位点,这些位点可以容纳有效的亲和标签的掺入,而不会显著损失病毒复制能力所需的那些结构/功能关系。结合一种新的低温方法来捕获和保存免疫隔离过程中短暂的病毒-宿主相互作用,我们已经恢复了几个与复制病毒相关的宿主蛋白,但以前从传统的科学调查中被掩盖。我们确信,我们的方法是合理的,因为在使用我们的方法回收和鉴定的细胞蛋白质中,有那些先前由其他小组确定与HIV-1相互作用的蛋白质。此外,一个简单的质谱技术,提出了高精度的特异性和非特异性蛋白质之间的免疫分离的蛋白质复合物的歧视。所描述的组合的遗传和蛋白质组学方法是一个强大的工具集,其可用于鉴定在病毒生命周期期间的点处与给定病毒蛋白质瞬时相关的细胞蛋白质,其中的一个子集可能是病毒对其生计绝对需要的,但部分是由宿主细胞替代的。公共卫生相关性:考虑到细胞内生物学过程的已知复杂性以及HIV-1基因组的小编码大小所施加的严格限制,可以合理地预期HIV-1蛋白质组必须依赖于一组宿主因子阵列来完成其细胞内任务。为了恢复和鉴定与病毒机制复杂相互作用的必需宿主蛋白,我们已经开发了一种系统的方法来选择可以编码小但有效的外源表位标签但在培养中保持完全复制能力的衍生物。结合一种新的低温方法来捕获和保存短暂的病毒-宿主相互作用,我们已经恢复和鉴定了存在于病毒/宿主界面的新的宿主蛋白(与HIV-1相关,但以前从传统的科学研究中被掩盖),其中一个子集可能有潜力为针对这种病毒的小分子干预提供新的靶点。
英文摘要
DESCRIPTION (provided by applicant): Given the limited genetic coding capacity of HIV-1, it is reasonable to expect that the virus must interact with an extensive battery of cellular factors to complete its passage through the cell. Indeed, it is remarkable that the viral genome, comprising only about 0.0003% of the entire genetic capacity of the cell, commandeers the cellular environment to its own advantage. However, to date and despite being easily the most studied virus, only a relatively small group of cellular proteins have been shown essential for HIV-1 propagation. A genetic/proteomic approach has been developed that utilizes a random mutagenic protocol followed by a stringent step of biological selection in efforts to pinpoint those rare sites within the HIV-1 proteome that can accommodate the incorporation of a potent affinity tag without significant loss of those structure/function relationships that are required for viral replication-competency. In conjunction with a novel cryogenic methodology to capture and preserve transient viral-host interactions during immunoisolation, we have recovered several host proteins in association with the replicating virus but previously obscured from conventional scientific investigation. We are reassured that our method is sound since among the cellular proteins recovered and identified using our methodologies are those previously determined by other groups to interact with HIV-1. Furthermore, a straightforward mass spectrometric technique is presented that discriminates with high accuracy between specific and nonspecific proteins in immunoisolated protein complexes. The combined genetic and proteomic method described is a powerful tool set that can be utilized to identify cellular proteins in transient association with a given viral protein at points during the viral life cycle, a subset of which may be absolutely required by the virus for its livelihood but in part, dispensable by the host cell. PUBLIC HEALTH RELEVANCE: Given the known complexity of biological processes within the cell as well as the rigid constraints imposed by the small coding size of the HIV-1 genome, it is reasonable to expect that the HIV-1 proteome must rely upon a battery of host factor arrays to complete its intracellular tasks. In an effort to recover and identify requisite host proteins that interact in complex with the viral machinery, we have developed a systematic method to select derivatives that can encode a small, but potent, foreign epitope tag yet remain fully replication-competent in culture. In conjunction with a novel cryogenic methodology to capture and preserve transient viral-host interactions, we have recovered and identified new sets of host proteins existing at the viral/host interface (in association with HIV-1 but previously obscured from conventional scientific investigation), a subset of which may have the potential to provide a new targets for small molecule intervention against this virus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Maturational Intermediates of Trimeric HIV-1 Envelope as Unique Immunogens
-
批准号:8790245
-
项目类别:
-
资助金额:$28.48万
-
财政年份:2014
-
负责人:MARK AYER MUESING
-
依托单位:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
-
批准号:8361508
-
项目类别:
-
资助金额:$6.72万
-
财政年份:2011
-
负责人:MARK AYER MUESING
-
依托单位:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
-
批准号:8169125
-
项目类别:
-
资助金额:$9.5万
-
财政年份:2010
-
负责人:MARK AYER MUESING
-
依托单位:
Revealing the HIV-1 Interactome
-
批准号:8415922
-
项目类别:
-
资助金额:$42.03万
-
财政年份:2009
-
负责人:MARK AYER MUESING
-
依托单位:
Revealing the HIV-1 Interactome
-
批准号:8016699
-
项目类别:
-
资助金额:$44.72万
-
财政年份:2009
-
负责人:MARK AYER MUESING
-
依托单位:
Revealing the HIV-1 Interactome
-
批准号:7685768
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2009
-
负责人:MARK AYER MUESING
-
依托单位:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
-
批准号:7954081
-
项目类别:
-
资助金额:$9.26万
-
财政年份:2009
-
负责人:MARK AYER MUESING
-
依托单位:
Revealing the HIV-1 Interactome
-
批准号:7916902
-
项目类别:
-
资助金额:$24.85万
-
财政年份:2009
-
负责人:MARK AYER MUESING
-
依托单位:
Revealing the HIV-1 Interactome
-
批准号:7766256
-
项目类别:
-
资助金额:$45.17万
-
财政年份:2009
-
负责人:MARK AYER MUESING
-
依托单位:
HIV INTEGRASE SH3 INTERACTIONS
-
批准号:7722234
-
项目类别:
-
资助金额:$0.41万
-
财政年份:2008
-
负责人:MARK AYER MUESING
-
依托单位:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
-
批准号:7722221
-
项目类别:
-
资助金额:$5.51万
-
财政年份:2008
-
负责人:MARK AYER MUESING
-
依托单位:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
-
批准号:7355109
-
项目类别:
-
资助金额:$5.52万
-
财政年份:2006
-
负责人:MARK AYER MUESING
-
依托单位:
HIV INTEGRASE SH3 INTERACTIONS
-
批准号:7355128
-
项目类别:
-
资助金额:$0.83万
-
财政年份:2006
-
负责人:MARK AYER MUESING
-
依托单位:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
-
批准号:7180016
-
项目类别:
-
资助金额:$9.34万
-
财政年份:2005
-
负责人:MARK AYER MUESING
-
依托单位:
A Genetic/Proteomic Approach to Virus-Host Interactions
-
批准号:7006367
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2005
-
负责人:MARK AYER MUESING
-
依托单位:
IDENTIFYING PHOSPHORYLATION SITES OF HIV INTEGRASE BY MASS SPECTROMETRY
-
批准号:7179934
-
项目类别:
-
资助金额:$0.47万
-
财政年份:2005
-
负责人:MARK AYER MUESING
-
依托单位:
A Genetic/Proteomic Approach to Virus-Host Interactions
-
批准号:7140585
-
项目类别:
-
资助金额:$26.37万
-
财政年份:2005
-
负责人:MARK AYER MUESING
-
依托单位:
Inhibition of Integrase-Mediated Viral Nuclear Transport
-
批准号:6843072
-
项目类别:
-
资助金额:$27.31万
-
财政年份:2004
-
负责人:MARK AYER MUESING
-
依托单位:
Inhibition of Integrase-Mediated Viral nuclear Transport
-
批准号:6954149
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2004
-
负责人:MARK AYER MUESING
-
依托单位:
IDENTIFYING PHOSPHORYLATION SITES OF HIV INTEGRASE
-
批准号:6975799
-
项目类别:
-
资助金额:$0.61万
-
财政年份:2004
-
负责人:MARK AYER MUESING
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: